ÀºÇòÅâÂÊ

Home Biotechnology Gene Delivery Technologies Market Analysis, Trends to 2030

Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode  (Biological, Chemical, Physical), By Application  (Gene Therapy, Cell Therapy, Vaccines, Research), By Method (Ex-vivo, In-vivo, In-vitro) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRBI2279DR
Author : ÀºÇòÅâÂÊ

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Gene Delivery Technologies Market Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    1. Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    5. U.S.
      1. By Mode 
        1. Introduction
          1. Mode  By Value
        2. Biological
          1. By Value
        3. Chemical
          1. By Value
        4. Physical
          1. By Value
      2. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene Therapy
          1. By Value
        3. Cell Therapy
          1. By Value
        4. Vaccines
          1. By Value
        5. Research
          1. By Value
      3. By Method
        1. Introduction
          1. Method By Value
        2. Ex-vivo
          1. By Value
        3. In-vivo
          1. By Value
        4. In-vitro
          1. By Value
    6. Canada
    1. Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    5. U.K.
      1. By Mode 
        1. Introduction
          1. Mode  By Value
        2. Biological
          1. By Value
        3. Chemical
          1. By Value
        4. Physical
          1. By Value
      2. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene Therapy
          1. By Value
        3. Cell Therapy
          1. By Value
        4. Vaccines
          1. By Value
        5. Research
          1. By Value
      3. By Method
        1. Introduction
          1. Method By Value
        2. Ex-vivo
          1. By Value
        3. In-vivo
          1. By Value
        4. In-vitro
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    5. China
      1. By Mode 
        1. Introduction
          1. Mode  By Value
        2. Biological
          1. By Value
        3. Chemical
          1. By Value
        4. Physical
          1. By Value
      2. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene Therapy
          1. By Value
        3. Cell Therapy
          1. By Value
        4. Vaccines
          1. By Value
        5. Research
          1. By Value
      3. By Method
        1. Introduction
          1. Method By Value
        2. Ex-vivo
          1. By Value
        3. In-vivo
          1. By Value
        4. In-vitro
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    5. UAE
      1. By Mode 
        1. Introduction
          1. Mode  By Value
        2. Biological
          1. By Value
        3. Chemical
          1. By Value
        4. Physical
          1. By Value
      2. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene Therapy
          1. By Value
        3. Cell Therapy
          1. By Value
        4. Vaccines
          1. By Value
        5. Research
          1. By Value
      3. By Method
        1. Introduction
          1. Method By Value
        2. Ex-vivo
          1. By Value
        3. In-vivo
          1. By Value
        4. In-vitro
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Mode 
      1. Introduction
        1. Mode  By Value
      2. Biological
        1. By Value
      3. Chemical
        1. By Value
      4. Physical
        1. By Value
    3. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene Therapy
        1. By Value
      3. Cell Therapy
        1. By Value
      4. Vaccines
        1. By Value
      5. Research
        1. By Value
    4. By Method
      1. Introduction
        1. Method By Value
      2. Ex-vivo
        1. By Value
      3. In-vivo
        1. By Value
      4. In-vitro
        1. By Value
    5. Brazil
      1. By Mode 
        1. Introduction
          1. Mode  By Value
        2. Biological
          1. By Value
        3. Chemical
          1. By Value
        4. Physical
          1. By Value
      2. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene Therapy
          1. By Value
        3. Cell Therapy
          1. By Value
        4. Vaccines
          1. By Value
        5. Research
          1. By Value
      3. By Method
        1. Introduction
          1. Method By Value
        2. Ex-vivo
          1. By Value
        3. In-vivo
          1. By Value
        4. In-vitro
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Gene Delivery Technologies Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. QIAGEN
    3. Horizon Discovery Group Co.
    4. OriGene Technologies, Inc.
    5. Oxford Biomedica
    6. SignaGen Laboratories
    7. Vectalys
    8. Takara Bio Inc.
    9. Bio-Rad Laboratories, Inc.
    10. System Biosciences LLC
    11. Promega Corporation
    12. Hoffmann-La Roche AG
    13. Sirion-Biotech GmbH
    14. Catalent Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Drug Delivery Technologies Market Size The global drug delivery technologies market size was valued at USD 1.50 billion in 2024 and is projected to grow from USD 1.8 billion in 2025 to reach USD 7.57 billion by 2033, exhibiting a CAGR of 19.7%
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :